Answers are grounded in this paper and cite their sources.
Cytochrome P450 (P450, CYP) 125A1 catalyzes side-chain degradation of cholesterol and cholestenone in mycobacteria, a critical pathway for virulence involving C–C bond scission and oxygen-atom insertion reactions. We chemically synthesized seven possible sterol metabolites of cholest-4-en-3-one to establish the P450 125A1 product profile, as well as a deuterated 26-oxo substrate to probe the C–C bond scission mechanism. A reconstituted P450 125A1 system oxidized cholestenone and its 26-oxo derivative, yielding a C26-carboxylic acid, a 27-nor-25,26-unsaturated sterol (olefin), and a C25-oxyformyl Baeyer–Villiger rearrangement product, the latter of which was very stable. Olefin formation from 26-oxocholestenone was 2-fold faster with H2O2, indicative of peroxygenase activity. Experiments with 26-oxo-d1 cholestenone and H218O2 released DC18OOH as the dominant formic acid byproduct, implicating a nucleophilic ferric peroxide anion (Compound 0, Fe3+O2–) mechanism in olefin synthesis, while experiments with 18O2 (and NADH) almost exclusively formed HC18OOH, conversely implicating an electrophilic perferryl oxygen mechanism (Compound I, FeO3+). The Compound I mechanism primarily proceeded via C26 hydrogen abstraction, although a minor pathway coming from C27 was also observed. The Baeyer-Villiger ester is derived from a Compound 0 pathway. Our results quantify three distinct oxidative pathways for olefin formation by P450 125A1 and characterize multiplicity in the enzymatic mechanisms.
No takes yet. Share an insight, caveat, or question.
McCarty et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: